š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Study to compare the lung and oropharyngeal deposition of BerodualĀ® (fenote...
Status
Terminated
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT02176200
Treatments Being Tested
The aim of this postmarketing surveillance is to obtain further information...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT02231424
Treatments Being Tested
Tolerability, efficacy and handling of BerodualĀ® RespimatĀ® 20/50Āµg/dose sol...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT02231359
Treatments Being Tested
Study to demonstrate that at least one of the two doses of BerodualĀ® (50 Āµg...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02182505
Treatments Being Tested
To determine efficacy and tolerability of inhaled Formoterol vs nebulized I...
Status
Completed
Location
Novartis Investigator site - five sites in Caracas
Start Date
2007-03
Trial ID
NCT00460577
Treatments Being Tested
The goal of this clinical is to compare treatment outcomes between continuo...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04
Trial ID
NCT06291740
Treatments Being Tested
Study to compare the effect of 'natural' as opposed to 'optimal' technique ...
Status
Terminated
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT02176187
Treatments Being Tested
The primary objective of this study was to investigate patients acceptabili...
Status
Completed
Location
Multiple Locations
Start Date
2002-10
Trial ID
NCT02173795
Treatments Being Tested
The aim of this post-marketing surveillance is to obtain further informatio...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT02231437
Treatments Being Tested
Tolerability, efficacy and handling of BerodualĀ® RespimatĀ® 20/50Āµg/dose sol...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT02231372
Treatments Being Tested